Showing results (11-20 of 217) with videos related to
Sort By:
Pageof 22
Frontiers in Medicine|April 9, 2020
Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving ConceptThierry Berghmans, Valérie Durieux, Lizza E L Hendriks, et al.Cancer Treatment Reviews|September 26, 2020
EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history beginsJordi Remon, Lizza E L Hendriks, Andres F Cardona, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR-Mutant TumorsStephanie P L Saw, Xiuning Le, Lizza E L Hendriks, et al.Cancer Investigation|May 13, 2022
Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022Sankalp Arora, Palash Asawa, Nilansh Kataria, et al.Nederlands Tijdschrift Voor Geneeskunde|January 19, 2013
[A man with persisting dyspnea]Lizza E L Hendriks, Michiel H M Gronenschild, Eric H J van HarenCells|April 30, 2021
Biomarkers of Radiotherapy-Induced Immunogenic Cell DeathRianne D W Vaes, Lizza E L Hendriks, Marc Vooijs, et al.European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoringMart Schiefer, Lizza E L Hendriks, Trang Dinh, et al.Therapeutic Advances in Medical Oncology|August 4, 2022
Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?Jordi Remon, Antonin Levy, Pawan Singh, et al.Cancers|April 30, 2021
Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?Stephanie T H Peeters, Evert J Van Limbergen, Lizza E L Hendriks, et al.Cancer Treatment Reviews|July 7, 2024
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trialsMartina Bortolot, Francesco Cortiula, Gianpiero Fasola, et al.Pageof 22